Synthomer Completes Divestment of William Blythe to Strengthen Financial Position

An update from Synthomer ( (GB:SYNT) ) is now available.

Synthomer plc has completed the divestment of its subsidiary, William Blythe Limited, for £30 million, with net cash proceeds of £25 million used to reduce the Group’s debt. This divestment is part of Synthomer’s strategic efforts to streamline operations and focus on its core business areas, potentially enhancing its market position and financial stability.

The most recent analyst rating on (GB:SYNT) stock is a Buy with a £275.00 price target. To see the full list of analyst forecasts on Synthomer stock, see the GB:SYNT Stock Forecast page.

Spark’s Take on GB:SYNT Stock

According to Spark, TipRanks’ AI Analyst, GB:SYNT is a Neutral.

The most significant factor is Synthomer’s poor financial performance, which heavily impacts the overall score. While technical analysis shows some positive trends, the company’s valuation remains unattractive due to negative earnings. However, strategic corporate actions provide a positive outlook, indicating potential future improvements.

To see Spark’s full report on GB:SYNT stock, click here.

More about Synthomer

Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients, serving key sectors such as coatings, construction, adhesives, and health and protection. Headquartered in London, UK, the company operates 29 manufacturing sites across Europe, North America, the Middle East, and Asia, with a focus on sustainability and innovation. Synthomer collaborates closely with its customers to develop new products and enhance existing ones, with a significant portion of its sales coming from new and patent-protected products.

Average Trading Volume: 823,228

Technical Sentiment Signal: Sell

Current Market Cap: £171.1M

For detailed information about SYNT stock, go to TipRanks’ Stock Analysis page.